Morgan Stanley Direct Lending Fund trades at a 27% NAV discount amid exaggerated SaaS sector fears. Check out why MSDL stock ...

GigaCloud proves the bears wrong by reporting a resilient double-digit growth profile in the EU. Read why GCT stock is ...

Energy Fuels has surged nearly 400% since last April, outperforming uranium and rare earth peers. Read why I retain a hold rating for UUUU stock.

Verisk Analytics' recent slump aligns with an industry-wide downturn, as evidenced by similar trends in Moody's and Experian.

Strike Energy Limited ( STKKF) Q2 2026 Earnings Call February 25, 2026 8:00 PM EST ...

BeOne Medicines Q4 earnings and revenue beat the Street's expectations; the outlook missed by a small margin. Read why I have ...

SCZ ETF review: diversification and 2025 gains vs a 0.40% expense ratio, Japan concentration and currency risk.

SPYD's equal weighting, sector diversification, and income orientation position it as a defensive core allocation amid ...

Acadia Pharmaceuticals' two approved drugs, NUPLAZID and DAYBUE are guided to continue their strong growth trajectories. Read why ACAD stock is a buy.

SPYI has delivered 42 consecutive monthly distributions totaling $20.99 since inception, averaging a 12.21% annualized yield. Read why the SPYI ETF is a buy.

Cal-Maine Foods remains fundamentally robust, trading at low multiples with a solid net cash and market cap position. Find out why CALM stock is a hold.

Capital Southwest (CSWC), and Ares Capital (ARCC) and share what we're buying recently. Read the full analysis here.